TCEAL1 Activators
The functional activity of TCEAL1, a transcription elongation factor, is intricately tied to the cellular mechanisms controlling gene expression. Certain compounds can lead to an upregulation of intracellular secondary messengers such as cyclic AMP, which activates protein kinases that phosphorylate and regulate the activity of transcription factors. This cascade of events can culminate in the enhanced transcriptional activity of TCEAL1. Similarly, the elevation of intracellular calcium levels triggers a series of reactions involving calcium-dependent protein kinases, which can also influence the transcription machinery in which TCEAL1 is a critical component. These activators work by altering the transcriptional landscape, creating a conducive environment for the functional role of TCEAL1 in transcription elongation.
Moreover, the modulation of epigenetic markers is another avenue through which the activity of TCEAL1 can be influenced. Inhibitors of DNA methylation and histone deacetylation can lead to a less condensed chromatin state, thereby increasing the accessibility of the transcriptional machinery to DNA and potentially enhancing the transcription of genes where TCEAL1 serves as a co-factor. Additionally, the inhibition of specific histone methyltransferases and kinases involved in the phosphorylation of transcription factors can stabilize and potentiate these factors, which may augment the regulatory influence of TCEAL1 on gene expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator that leads to an increase in cyclic AMP (cAMP) levels, subsequently activating PKA. PKA can phosphorylate various transcription factors that may enhance the transcriptional activity of TCEAL1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific phosphodiesterase inhibitor that prevents the degradation of cAMP, thereby sustaining PKA activation which could promote TCEAL1 function by enhancing the transcription of genes where TCEAL1 is a co-factor. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Protein kinase C (PKC) activator that can modulate the phosphorylation status of transcription factors and co-factors, potentially increasing the transcriptional activity of TCEAL1. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
Synthetic analog of cAMP that activates PKA, leading to the phosphorylation of transcription factors that may be involved in the transcriptional regulation by TCEAL1. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent protein kinases affecting the transcription regulation by TCEAL1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
As a calcium ionophore, it elevates intracellular calcium and could activate pathways that influence TCEAL1's role in transcriptional regulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can lead to the hypomethylation of gene promoters, potentially increasing the transcription of TCEAL1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that can result in a more open chromatin structure, potentially enhancing the transcription of genes where TCEAL1 functions as a co-factor. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
G9a histone methyltransferase inhibitor that may alter chromatin structure, potentially increasing the transcriptional activity of TCEAL1. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
GSK-3 inhibitor that can lead to the stabilization and activation of transcription factors, potentially promoting the transcription activity where TCEAL1 is involved. | ||||||